ArticlePlacenta2025
Characterization of placental pathology in Beckwith-Wiedemann Syndrome due to alterations in the KCNQ1OT1:TSS-DMR region.
Article in Placenta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionBeckwith-Wiedemann Syndrome (BWS) is an imprinting disorder characterized by fetal and placental overgrowth. BWS is most often caused by genetic and epigenetic alterations involving the KCNQ1OT1-TSS:DMR (IC2) imprinting control region which alters expression of CDKN1C (p57KIP2). Here we report a cohort of patients with BWS primarily due to defects at IC2 compared to a well matched, non-BWS cohort to establish the placental features associated with these BWS subtypes.
methodsThis is a retrospective case-control study. Our cohort of 28 patients with BWS were matched to a non-BWS cohort of 28 unaffected patients. The rate of clinical and pathological features in the BWS and non-BWS cohorts were compared. Additionally, the associations between loss of p57KIP2 staining in the BWS cohort, placental pathology, and clinical outcomes were analyzed.
resultsWe identified key pathological features in the placenta associated with BWS including placentomegaly, umbilical cord edema, abnormal chorionic vascular pattern, macroscopic cysts, stem villous stromal expansion, and abnormal extravillous trophoblast (EVT) morphology. We found that placental overgrowth in BWS is disproportionate to fetal overgrowth. We also identified associations between abnormal EVT morphology, loss of p57KIP2 staining, and rates of prematurity in patients with BWS. DISCUSSION: Novel features associated with BWS identified in this work can be used to inform the diagnosis of BWS when examining the placenta. Additionally, by establishing associations between adverse pregnancy outcomes and abnormal EVT morphology, we identified a potential mechanism for the increased risk of prematurity in pregnancies complicated by BWS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.